Big win for patients! Go Kiyatec Inc.!
A revolutionary study was published today in Scientific Reports that demonstrates the impact of 3D Predict™ on high-grade glioma (HGG) patients, including how it significantly improves overall survival rates by accurately predicting their response to standard of care treatment. With HGGs being extremely aggressive, this study shows why our 3D Predict test is so instrumental in pinpointing the right treatment for brain cancer patients. You can read the entire study online here: https://lnkd.in/eUqD2-2F #3DPredict #HighGradeGliomas #BrainCancer #BrainTumors #OncologyInnovation #PrecisionMedicine